Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Ernexa Therapeutics Inc. has filed 1,510 SEC EDGAR filings since 14 Feb 1994

SEC filing history

Showing 926-950 of 1,000 matching filings.

Per page
25
Current page
38
8-K File 001-11460

FORM 8-K

Filing date
24 Jan 2012
Reporting date
24 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-178641

PROSPECTUS SUPPLEMENT

Filing date
24 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-178641

FORM 424(B)(3)

Filing date
12 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-178641

EFFECT filing

Filing date
11 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

CURRENT REPORT ON FORM 8-K

Filing date
06 Jan 2012
Reporting date
06 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-178641

AMENDMENT NO. 1 TO FORM S-3

Filing date
06 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-42217

SC 13D/A

Filing date
04 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Dec 2011
Reporting date
20 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

FORM 8-K

Filing date
20 Dec 2011
Reporting date
20 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-178641

FORM S-3 REGISTRATION STATEMENT

Filing date
20 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

CURRENT REPORT ON FORM 8-K

Filing date
10 Nov 2011
Reporting date
10 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

CURRENT REPORT ON FORM 8-K

Filing date
11 Oct 2011
Reporting date
04 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Sep 2011
Reporting date
13 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

FORM 8-K

Filing date
11 Aug 2011
Reporting date
11 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-42217

SC 13D/A filing

Filing date
22 Jun 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

CURRENT REPORT ON FORM 8-K

Filing date
21 Jun 2011
Reporting date
17 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Jun 2011
Reporting date
17 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Jun 2011
Reporting date
17 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Jun 2011
Reporting date
17 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-11460

NTN BUZZTIME, INC.

Filing date
13 May 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

NTN BUZZTIME, INC. FORM 8-K

Filing date
11 May 2011
Reporting date
11 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-42217

SC 13D/A filing

Filing date
04 May 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

CURRENT REPORT ON FORM 8-K

Filing date
03 May 2011
Reporting date
27 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .